Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
28-29
pubmed:dateCreated
2006-12-4
pubmed:abstractText
The formation of fibrils by amyloid beta-protein (Abeta) is considered as a key step in the pathology of Alzheimer's disease (AD). Inhibiting the aggregation of Abeta is a promising approach for AD therapy. In this study, we used biocompatible nanogels composed of a polysaccharide pullulan backbone with hydrophobic cholesterol moieties (cholesterol-bearing pullulan, CHP) as artificial chaperones to inhibit the formation of Abeta-(1-42) fibrils with marked amyloidgenic activity and cytotoxicity. The CHP-nanogels incorporated up to 6-8 Abeta-(1-42) molecules per particle and induced a change in the conformation of Abeta from a random coil to alpha-helix- or beta-sheet-rich structure. This structure was stable even after a 24-h incubation at 37 degrees C and the aggregation of Abeta-(1-42) was suppressed. Furthermore, the dissociation of the nanogels caused by the addition of methyl-beta-cyclodextrin released monomeric Abeta molecules. Nanogels composed of amino-group-modified CHP (CHPNH(2)) with positive charges under physiological conditions had a greater inhibitory effect than CHP-nanogels, suggesting the importance of electrostatic interactions between CHPNH(2) and Abeta for inhibiting the formation of fibrils. In addition, CHPNH(2) nanogels protected PC12 cells from Abeta toxicity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0014-5793
pubmed:author
pubmed:issnType
Print
pubmed:day
11
pubmed:volume
580
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6587-95
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17125770-Amyloid beta-Peptides, pubmed-meshheading:17125770-Animals, pubmed-meshheading:17125770-Biocompatible Materials, pubmed-meshheading:17125770-Cell Death, pubmed-meshheading:17125770-Cholesterol, pubmed-meshheading:17125770-Chromatography, Gel, pubmed-meshheading:17125770-Circular Dichroism, pubmed-meshheading:17125770-Coumarins, pubmed-meshheading:17125770-Glucans, pubmed-meshheading:17125770-Humans, pubmed-meshheading:17125770-Microscopy, Electron, Transmission, pubmed-meshheading:17125770-Models, Biological, pubmed-meshheading:17125770-Molecular Chaperones, pubmed-meshheading:17125770-Neurofibrils, pubmed-meshheading:17125770-PC12 Cells, pubmed-meshheading:17125770-Polyethylene Glycols, pubmed-meshheading:17125770-Polyethyleneimine, pubmed-meshheading:17125770-Protein Structure, Quaternary, pubmed-meshheading:17125770-Protein Structure, Secondary, pubmed-meshheading:17125770-Rats, pubmed-meshheading:17125770-Spectrometry, Fluorescence, pubmed-meshheading:17125770-Temperature
pubmed:year
2006
pubmed:articleTitle
Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones.
pubmed:affiliation
Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't